Lakefront Biotherapeutics (LKFT)
29.52
-0.48
(-1.60%)
USD |
NASDAQ |
Oct 08, 16:00
29.52
0.00 (0.00%)
After-Hours: 18:27
Lakefront Biotherapeutics Debt to Equity Ratio : 0.0019 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0019 |
| March 31, 2026 | 0.002 |
| December 31, 2025 | 0.0021 |
| September 30, 2025 | 0.0031 |
| June 30, 2025 | 0.0032 |
| March 31, 2025 | 0.004 |
| December 31, 2024 | 0.004 |
| September 30, 2024 | 0.004 |
| June 30, 2024 | 0.0037 |
| March 31, 2024 | 0.0028 |
| September 30, 2023 | 0.0054 |
| June 30, 2023 | 0.006 |
| March 31, 2023 | 0.0062 |
| December 31, 2022 | 0.0087 |
| September 30, 2022 | 0.0084 |
| June 30, 2022 | 0.0091 |
| March 31, 2022 | 0.0096 |
| December 31, 2021 | 0.0102 |
| September 30, 2021 | 0.0101 |
| June 30, 2021 | 0.0105 |
| March 31, 2021 | 0.0106 |
| December 31, 2020 | 0.011 |
| September 30, 2020 | 0.0107 |
| June 30, 2020 | 0.0098 |
| March 31, 2020 | 0.0088 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0088 |
| September 30, 2019 | 0.0098 |
| June 30, 2019 | 0.0224 |
| March 31, 2019 | 0.0213 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.0001 |
| December 31, 2016 | 0.0001 |
| September 30, 2016 | 0.0001 |
| June 30, 2016 | 0.0001 |
| March 31, 2016 | 0.0001 |
| December 31, 2015 | 0.0003 |
| September 30, 2015 | 0.0003 |
| December 31, 2005 | 0.1239 |
| September 30, 2005 | |
| June 30, 2005 | 0.0526 |
| March 31, 2005 | |
| December 31, 2004 | 0.1465 |
| September 30, 2004 | |
| June 30, 2004 | 0.1432 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Gilead Sciences, Inc. | 2.219 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alkermes Plc | 0.8695 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Amarin Corp. Plc | 0.0118 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.831B |
| Total Liabilities (Quarterly) | 100.11M |
| Shareholders Equity (Quarterly) | 3.731B |
| Current Ratio | 32.82 |
| Net Debt Paydown Yield | 0.05% |